Product No. | Product Name | Size |
Prices effective: 01-Feb-06 | | |
ALX-160-008-M001 | [Trp4]-Kemptide | 1 mg |
ALX-160-008-M005 | [Trp4]-Kemptide | 5 mg |
ALX-160-009-C050 | Blocking Peptide for PAb to Kinesin-like Protein (mouse) (Prod. No. ALX-210-203) | 50.micro.g |
ALX-160-010-C050 | Blocking Peptide for PAb to Kinesin Motor Protein (mouse) (Prod. No. ALX-210-204) | 50.micro.g |
ALX-161-003-C050 | Blocking Peptide for PAb to Leptin Receptor (Prod. No. ALX-210-168) | 50.micro.g |
ALX-161-004-C050 | Blocking Peptide for PAb to Lysosome-Associated Membrane Protein-2 (Prod. No. ALX-210-206) | 50.micro.g |
ALX-162-001-M001 | Mastoparan | 1 mg |
ALX-162-001-M005 | Mastoparan | 5 mg |
ALX-162-002-MC05 | MCD Peptide | 0.5 mg |
ALX-162-004-M001 | MARCKS Protein (151-175) (bovine brain) | 1 mg |
ALX-162-004-MC05 | MARCKS Protein (151-175) (bovine brain) | 0.5 mg |
ALX-162-005-M001 | MARCKS Protein (159-165) amide (bovine brain) | 1 mg |
ALX-162-005-M005 | MARCKS Protein (159-165) amide (bovine brain) | 5 mg |
ALX-162-006-M001 | Melittin (natural) | 1 mg |
ALX-162-006-M005 | Melittin (natural) | 5 mg |
ALX-162-007-M001 | Melittin (synthetic) | 1 mg |
ALX-162-007-MC05 | Melittin (synthetic) | 0.5 mg |
ALX-162-009-M001 | Myelin Basic Protein (4-14) (bovine) | 1 mg |
ALX-162-009-M005 | Myelin Basic Protein (4-14) (bovine) | 5 mg |
ALX-162-010-M001 | Myelin Basic Protein (104-118) (bovine) | 1 mg |
ALX-162-010-M005 | Myelin Basic Protein (104-118) (bovine) | 5 mg |
ALX-162-011-M001 | Myosin Light Chain Kinase (11-19) amide | 1 mg |
ALX-162-011-M005 | Myosin Light Chain Kinase (11-19) amide | 5 mg |
ALX-162-012-M001 | Myosin Light Chain Kinase (342-352) amide | 1 mg |
ALX-162-012-M005 | Myosin Light Chain Kinase (342-352) amide | 5 mg |
ALX-162-013-M001 | Myosin Light Chain Kinase Substrate | 1 mg |
ALX-162-013-M005 | Myosin Light Chain Kinase Substrate | 5 mg |
ALX-162-016-M001 | [Pyr4]-Myelin Basic Protein (4-14) (bovine) | 1 mg |
ALX-162-016-M005 | [Pyr4]-Myelin Basic Protein (4-14) (bovine) | 5 mg |
ALX-162-017-M001 | N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH | 1 mg |
ALX-162-017-M005 | N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH | 5 mg |
ALX-162-018-M001 | N-Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH | 1 mg |
ALX-162-018-M005 | N-Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH | 5 mg |
ALX-162-019-M001 | [Ala96]-Myelin Basic Protein (87-99) (human, bovine, rat) | 1 mg |
ALX-162-019-M005 | [Ala96]-Myelin Basic Protein (87-99) (human, bovine, rat) | 5 mg |
ALX-162-021-C050 | Blocking Peptide for PAb to c-Myc Epitope Tag (Prod. No. ALX-210-208) | 50.micro.g |
ALX-162-024-1 | Blocking Peptide for PAb to Myosin VIIa (mouse) (Prod. No. ALX-210-227) | 1 Vial |
ALX-162-025-C050 | Blocking Peptide for PAb to UCP-3 (Prod. No. ALX-210-238) | 50.micro.g |
ALX-162-026-C050 | Blocking Peptide for PAb to Munc-18 (rat) (Prod. No. ALX-210-247) | 50.micro.g |
ALX-162-027-C050 | MALP-2 | 50.micro.g |
ALX-162-028-C050 | Blocking Peptide for PAb to Munc-18 Interacting Protein 3 [Mint3] (mouse) (Prod. No. ALX-210-348) | 50.micro.g |
ALX-162-029-C100 | Blocking Peptide for PAb to CCR4 (human) (Prod. No. ALX-210-622) | 100.micro.g |
ALX-162-030-MC05 | Myelin Oligodendrocyte Glycoprotein [MOG] (35-35) (mouse, rat) | 0.5 mg |
ALX-162-030-M001 | Myelin Oligodendrocyte Glycoprotein [MOG] (35-35) (mouse, rat) | 1 mg |
ALX-162-031-M001 | Myelin Proteolipid Protein [PLP] (139-151) (human, bovine, dog, mouse, rat) | 1 mg |
ALX-162-032-M001 | [Ser140]-Myelin Proteolipid Protein [PLP] (139-151) (human, bovine, dog, mouse, rat) | 1 mg |
ALX-162-033-M001 | Myelin Basic Protein [MBP] (87-99) (human, bovine, rat) | 1 mg |
ALX-163-001-P001 | Nociceptin | 1 mg* |
ALX-163-001-P005 | Nociceptin | 5 mg* |
ALX-163-002-P001 | Neurotensin | 1 mg* |
ALX-163-002-P005 | Neurotensin | 5 mg* |
ALX-163-003-P001 | NPY (human) | 1 mg* |
ALX-163-003-PC05 | NPY (human) | 0.5 mg* |
ALX-163-004-M001 | Neurogranin (28-43) | 1 mg |
ALX-163-005-C050 | Blocking Peptide for PAb to Nitric Oxide Synthase (Inducible) (mouse) (Prod. No. ALX-210-504) | 50.micro.g |
ALX-163-007-C050 | Blocking Peptide for PAb to N-CoR (mouse) (Prod. No. ALX-210-254) | 50.micro.g |
ALX-163-008-C050 | Blocking Peptide for PAb to Na+ / Ca2+-K+ Exchanger (rat) (Prod. No. ALX-210-292) | 50.micro.g |
ALX-163-009-C050 | Blocking Peptide for MAb to Nuclear Factor of Activated T cells, Cytoplasmic 2 (Prod. No. ALX-804-215) | 50.micro.g |
ALX-163-011-1 | NBD [NF-kappaB Blocker] Peptide (cell permeable) | 1 Vial |
ALX-163-012-C050 | Blocking Peptide for PAb to Nitric Oxide Synthase (neuronal) (rat) (phosphorylated) (pSer1416) (Prod. No. ALX-210-528) | 50.micro.g |
ALX-163-013-C050 | Blocking Peptide for PAb to Nitric Oxide Synthase (Neuronal) (rat) (Prod. No. ALX-210-529) | 50.micro.g |
ALX-163-014-C050 | Blocking Peptide for PAb to Nicastrin (Prod. No. ALX-210-561) | 50.micro.g |
ALX-164-001-C100 | Orexin A (human, bovine, rat, mouse) | 100.micro.g |
ALX-164-001-C500 | Orexin A (human, bovine, rat, mouse) | 500.micro.g |
ALX-164-001-M001 | Orexin A (human, bovine, rat, mouse) | 1 mg |
ALX-164-002-C100 | Orexin B (human) | 100.micro.g |
ALX-164-003-C100 | Orexin B (rat, mouse) | 100.micro.g |
ALX-164-004-M001 | Obestatin (human) | 1 mg |
ALX-164-004-M005 | Obestatin (human) | 5 mg |
ALX-164-005-M001 | Obestatin (mouse, rat) | 1 mg |
ALX-164-005-M005 | Obestatin (mouse, rat) | 5 mg |
ALX-165-001-M001 | GP Antagonist-2 | 1 mg |
ALX-165-001-M005 | GP Antagonist-2 | 5 mg |
ALX-165-002-M001 | [D-Trp7,9,10]-Substance P | 1 mg |
ALX-165-002-M005 | [D-Trp7,9,10]-Substance P | 5 mg |
ALX-165-003-M001 | PACAP (1-27) (human, sheep, rat) | 1 mg |
ALX-165-003-MC05 | PACAP (1-27) (human, sheep, rat) | 0.5 mg |
ALX-165-004-M001 | pp60v-src (137-157) | 1 mg |
ALX-165-004-MC01 | pp60v-src (137-157) | 0.1 mg |
ALX-165-005-M001 | PDGF beta-Receptor (719-723) (Phosphorylated) | 1 mg |
ALX-165-005-M005 | PDGF beta-Receptor (719-723) (Phosphorylated) | 5 mg |
ALX-165-006-M001 | Peptide epsilon | 1 mg |
ALX-165-006-M005 | Peptide epsilon | 5 mg |
ALX-165-006-MC01 | Peptide epsilon | 0.1 mg |
ALX-165-007-M001 | Phospholipase A2 Activating Peptide | 1 mg |
ALX-165-007-MC01 | Phospholipase A2 Activating Peptide | 0.1 mg |
ALX-165-009-M001 | Protein Kinase C (19-31) | 1 mg |
ALX-165-009-M005 | Protein Kinase C (19-31) | 5 mg |
ALX-165-010-M001 | Protein Kinase C (19-36) | 1 mg |
ALX-165-010-M005 | Protein Kinase C (19-36) | 5 mg |
ALX-165-011-MC01 | Protein Kinase C (530-558) | 0.1 mg |
ALX-165-013-M001 | Protein Kinase C Substrate | 1 mg |
ALX-165-013-M005 | Protein Kinase C Substrate | 5 mg |
ALX-165-017-M001 | [Ser25]-Protein Kinase C (19-31) | 1 mg |
ALX-165-017-M005 | [Ser25]-Protein Kinase C (19-31) | 5 mg |
ALX-165-018-M001 | Protein Kinase p34cdc2 Substrate | 1 mg |
ALX-165-019-M001 | PDGF Fragment (Phosphorylated) (cyclic) | 1 mg |
ALX-165-019-MC01 | PDGF Fragment (Phosphorylated) (cyclic) | 0.1 mg |
ALX-165-020-M001 | Protein Tyrosine Phosphatase Substrate | 1 mg |
ALX-165-020-M005 | Protein Tyrosine Phosphatase Substrate | 5 mg |
ALX-165-022-M001 | pp60c-src (521-533) (Phosphorylated) | 1 mg |
ALX-165-022-M005 | pp60c-src (521-533) (Phosphorylated) | 5 mg |
ALX-165-022-MC05 | pp60c-src (521-533) (Phosphorylated) | 0.5 mg |
ALX-165-023-M001 | pp60v-src Fragment | 1 mg |
ALX-165-023-M005 | pp60v-src Fragment | 5 mg |
ALX-165-024-M001 | PKI-tide | 1 mg |
ALX-165-024-M005 | PKI-tide | 5 mg |
ALX-165-025-M001 | PACAP (1-38) (human, sheep, rat) | 1 mg |
ALX-165-025-MC05 | PACAP (1-38) (human, sheep, rat) | 0.5 mg |
ALX-165-026-M001 | PACAP (6-38) (human, sheep, rat) | 1 mg |
ALX-165-026-MC05 | PACAP (6-38) (human, sheep, rat) | 0.5 mg |
ALX-165-027-C050 | Blocking Peptide for MAb to Progesterone Receptor [PR] (Prod. No. ALX-803-007) | 50.micro.g |
ALX-165-029-C050 | Blocking Peptide for PAb to PPARalpha (mouse) (Prod. No. ALX-210-190/1) | 50.micro.g |
ALX-165-030-C050 | Blocking Peptide for PAb to PPARdelta (mouse) (Prod. No. ALX-210-191/1) | 50.micro.g |
ALX-165-031-C050 | Blocking Peptide for PAb to PPARgamma2 (Prod. No. ALX-210-192) | 50.micro.g |
ALX-165-032-C100 | Blocking Peptide for PAb to Phosphatidyl-4-phosphate 5-kinase-Igamma (Prod. No. ALX-210-745) | 100.micro.g |
ALX-165-033-C100 | Blocking Peptide for PAb to p56dok-2 (human) (Prod. No. ALX-210-746) | 100.micro.g |
ALX-165-034-C100 | Blocking Peptide for PAb to Phosphoinositide 3-Kinase p110delta (human) (Prod. No. ALX-210-747) | 100.micro.g |
ALX-165-035-C050 | Blocking Peptide for PAb to Prion Protein (sheep) (Prod. No. ALX-210-200) | 50.micro.g |
ALX-165-036-C050 | Blocking Peptide for PAb to Peroxisomal Membrane Protein 70 (mouse) (Prod. No. ALX-210-205) | 50.micro.g |
ALX-165-038-C050 | Blocking Peptide for PAb to p300 (human) (Prod. No. ALX-210-228) | 50.micro.g |
ALX-165-039-C050 | Blocking Peptide for PAb to Akt (mouse) (Prod. No. ALX-210-226) | 50.micro.g |
ALX-165-040-C100 | Blocking Peptide for PAb to p51A (Prod. No. ALX-210-768) | 100.micro.g |
ALX-165-041-C100 | Blocking Peptide for PAb to p51B (Prod. No. ALX-210-769) | 100.micro.g |
ALX-165-042-C100 | Blocking Peptide for PAb to pp36 (human) (Prod. No. ALX-210-770) | 100.micro.g |
ALX-165-043-C050 | Blocking Peptide for PAb to PER1 (mouse) (Prod. No. ALX-210-246) | 50.micro.g |
ALX-165-044-C050 | Blocking Peptide for PAb to PAR-4 (Prod. No. ALX-210-248) | 50.micro.g |
ALX-165-045-C050 | Blocking Peptide for PAb to PSD-93 (rat) (Prod. No. ALX-210-266) | 50.micro.g |
ALX-165-046-C050 | Blocking Peptide for MAb to Prion Protein (Prod. No. ALX-803-042) | 50.micro.g |
ALX-165-047-C050 | Blocking Peptide for PAb to Proteasome Activator 11S (Subunit REGgamma) (Prod. No. ALX-210-297) | 50.micro.g |
ALX-165-048-C050 | Blocking Peptide for PAb to Proteasome Activator 11S (Subunit REGalpha) (Prod. No. ALX-210-298) | 50.micro.g |
ALX-165-049-C050 | Blocking Peptide for PAb to Proteasome 20S (Subunit C2) (Prod. No. ALX-210-295) | 50.micro.g |
ALX-165-050-C050 | Blocking Peptide for PAb to Proteasome 19S (Subunit S10B) (Prod. No. ALX-210-296) | 50.micro.g |
ALX-165-051-C050 | Blocking Peptide for PAb to PICK1 (Prod. No. ALX-210-349) | 50.micro.g |
ALX-165-052-C500 | Peptide YY (3-36) (human) | 500.micro.g |
ALX-165-053-C050 | Blocking Peptide for PAb to Perilipin A (mouse) (Prod. No. ALX-210-358) | 50.micro.g |
ALX-165-054-C050 | Blocking Peptide for PAb to Perilipin A/B (mouse) (Prod. No. ALX-210-359) | 50.micro.g |
ALX-165-055-C050 | Blocking Peptide for PAb to PPARalpha (mouse) (phosphorylated) (pSer12) (Prod. No. ALX-210-361) | 50.micro.g |
ALX-165-056-C050 | Blocking Peptide for PAb to PPARalpha (mouse) (phosphorylated) (pSer21) (Prod. No. ALX-210-362) | 50.micro.g |
ALX-165-057-C200 | Blocking Peptide for PAb to PAF Receptor (human) (Prod. No. ALX-210-715) | 200.micro.g |
ALX-165-066-M002 | Pam3Cys-Ser-(Lys)4 . trihydrochloride | 2 mg |
ALX-165-067-1 | PUMA (135-154) (cell permeable) | 1 Vial |
ALX-165-068-C050 | Blocking Peptide for PAb to PDIA6 (human) (Prod. No. ALX-210-889) | 50.micro.g |
ALX-165-069-M001 | Pam3CysSK4 (Aca-Aca-Biotin) | 1 mg |
ALX-166-001-M001 | Ras Inhibitory Peptide | 1 mg |
ALX-166-001-M005 | Ras Inhibitory Peptide | 5 mg |
ALX-166-002-M001 | R-R-SRC-Peptide | 1 mg |
ALX-166-002-M005 | R-R-SRC-Peptide | 5 mg |
ALX-166-003-C050 | Blocking Peptide for PAb (Prod. No. ALX-210-156) & MAb (Prod. No. ALX-804-102) to Retinoic Acid Receptor alpha | 50.micro.g |
ALX-166-004-C050 | Blocking Peptide for PAb (Prod. No. ALX-210-157) & MAb (Prod. No. ALX-804-103) to Retinoic Acid Receptor beta | 50.micro.g |
ALX-166-005-C050 | Blocking Peptide for PAb to RIP140 (Prod. No. ALX-210-284) | 50.micro.g |
ALX-166-006-C050 | Blocking Peptide for PAb to RbAp46 (human) (Prod. No. ALX-210-287) | 50.micro.g |
ALX-166-007-C050 | Blocking Peptide for PAb to RbAp48 (human) (Prod. No. ALX-210-288) | 50.micro.g |
ALX-166-008-C050 | Blocking Peptide for PAb to Rab 3D (mouse) (Prod. No. ALX-210-855) | 50.micro.g |
ALX-166-009-C050 | Blocking Peptide for PAb to Resistin (mouse) (Prod. No. ALX-210-357) | 50.micro.g |
ALX-167-001-P001 | Sarafotoxin S6b | 1 mg* |
ALX-167-001-PC01 | Sarafotoxin S6b | 0.1 mg* |
ALX-167-001-PC05 | Sarafotoxin S6b | 0.5 mg* |
ALX-167-002-P001 | Sarafotoxin S6c | 1 mg* |
ALX-167-002-PC01 | Sarafotoxin S6c | 0.1 mg* |
ALX-167-002-PC05 | Sarafotoxin S6c | 0.5 mg* |
ALX-167-003-M001 | Substance P | 1 mg |
ALX-167-003-M005 | Substance P | 5 mg |
ALX-167-004-P001 | Somatostatin-14 | 1 mg* |
ALX-167-004-P005 | Somatostatin-14 | 5 mg* |
ALX-167-006-M001 | S6 Phosphate Acceptor Peptide | 1 mg |
ALX-167-006-M005 | S6 Phosphate Acceptor Peptide | 5 mg |
ALX-167-007-M001 | Syntide 2 | 1 mg |
ALX-167-007-M005 | Syntide 2 | 5 mg |
ALX-167-009-M001 | Sauvagine | 1 mg |
ALX-167-009-MC05 | Sauvagine | 0.5 mg |
ALX-167-010-C050 | Blocking Peptide for PAb to Ca2+-Sensing Receptor (Prod. No. ALX-210-143) | 50.micro.g |
ALX-167-011-C050 | Blocking Peptide for PAb to SERCA3 ATPase (Prod. No. ALX-210-167/1) | 50.micro.g |
ALX-167-016-C050 | Blocking Peptide for PAb to SAP97 (rat) (Prod. No. ALX-210-267) | 50.micro.g |
ALX-167-017-C050 | Blocking Peptide for PAb to SAP102 (rat) (Prod. No. ALX-210-268) | 50.micro.g |
ALX-167-018-C050 | Blocking Peptide for PAb to SNAP-25 (Prod. No. ALX-210-279) | 50.micro.g |
ALX-167-019-C050 | Blocking Peptide for MAb to SMRT (human) (Prod. No. ALX-804-281 & ALX-804-282) | 50.micro.g |
ALX-167-020-C050 | Blocking Peptide for PAb to Steroid Receptor Coactivator-1 (Prod. No. ALX-210-283) | 50.micro.g |
ALX-167-021-C050 | Blocking Peptide for PAb to SAP97 (rat) (Prod. No. ALX-210-280) | 50.micro.g |
ALX-167-023-C050 | Blocking Peptide for PAb to b-Secretase (CT) (Prod. No. ALX-210-281) | 50.micro.g |
ALX-167-024-C500 | SN50 | 500.micro.g |
ALX-167-025-C500 | SN50M Control Peptide | 500.micro.g |
ALX-167-026-C050 | Blocking Peptide for PAb to SCAMP 1 (rat) (Prod. No. ALX-210-790) | 50.micro.g |
ALX-167-027-C050 | Blocking Peptide for PAb to SCAMP2 (Prod. No. ALX-210-857) | 50.micro.g |
ALX-168-003-M001 | Tyrosine Phosphorylation Site Inhibitor | 1 mg |
ALX-168-003-M005 | Tyrosine Phosphorylation Site Inhibitor | 5 mg |
ALX-168-004-M001 | H-Tyr-Ile-Tyr-Gly-Ser-Phe-Lys-OH | 1 mg |
ALX-168-004-M005 | H-Tyr-Ile-Tyr-Gly-Ser-Phe-Lys-OH | 5 mg |
ALX-168-005-M001 | Tyrosine Hydroxylase (24-33) (rat) | 1 mg |
ALX-168-006-C100 | Blocking Peptide for PAb to TRAIL-R3 (human) (Prod. No. ALX-210-744) | 100.micro.g |
ALX-168-007-C100 | Blocking Peptide for PAb to TRAIL-R2 (Prod. No. ALX-210-743) | 100.micro.g |
ALX-168-009-R050 | L-TAT Control Peptide (for Prod. No. ALX-159-600) | 50.micro.l |
ALX-168-009F-R050 | L-TAT Control Peptide (for Prod. No. ALX-159-600) | 50.micro.l |
ALX-168-010-R025 | D-TAT Control Peptide (for Prod. No. ALX-159-601) | 25.micro.l |
ALX-168-010F-R025 | D-TAT Control Peptide (for Prod. No. ALX-159-601) | 25.micro.l |
ALX-168-011-C100 | Blocking Peptide for PAb to Toll-like Receptor 2 (human) (Prod. No. ALX-210-852) | 100.micro.g |
ALX-168-012-C100 | Blocking Peptide for PAb to Toll-like Receptor 5 (human) (Prod. No. ALX-210-853) | 100.micro.g |
ALX-170-001-P001 | Vasoactive Intestinal Contractor (mouse) | 1 mg* |
ALX-170-001-PC01 | Vasoactive Intestinal Contractor (mouse) | 0.1 mg* |
ALX-170-001-PC05 | Vasoactive Intestinal Contractor (mouse) | 0.5 mg* |
ALX-170-002-C050 | Blocking Peptide for PAb to Voltage-Dependent Anion Channel (rat) (Prod. No. ALX-210-785) | 50.micro.g |
ALX-170-003-C050 | Blocking Peptide for PAb to TRPV1 [VR1] (rat) (Prod. No. ALX-210-318) | 50.micro.g |
ALX-170-004-C050 | Blocking Peptide for PAb to VAMP-3 (rat) (Prod. No. ALX-210-854) | 50.micro.g |
ALX-170-005-C050 | Blocking Peptide for PAb to TRPV1 [VR1] (human) (Prod. No. ALX-210-417) | 50.micro.g |
ALX-200-005-C500 | Calmodulin (human brain) (high purity) | 500.micro.g |
ALX-200-082-C100 | Vitronectin (human) | 100.micro.g |
ALX-200-087-C100 | Cystatin C (human) | 100.micro.g |
ALX-200-088-C002 | Transforming Growth Factor beta1 [TGF-beta1] (human) | 2.micro.g |
ALX-200-310-C100 | Cathepsin G (human neutrophils) | 100.micro.g |
ALX-200-314-1 | Cathepsin L (human) | 1 Vial |
ALX-200-418-C005 | MMP-1 Proenzyme (human) | 5.micro.g |
ALX-200-419-C005 | MMP-2 Proenzyme (human) | 5.micro.g |
ALX-200-420-C005 | MMP-2 / TIMP-2 Proenzyme Complex (human) | 5.micro.g |
ALX-200-421-C005 | MMP-8 Proenzyme (human) | 5.micro.g |
ALX-200-422-C005 | MMP-9 (human), Monomer | 5.micro.g |
ALX-200-423-C005 | MMP-9 (human), Dimer | 5.micro.g |
ALX-200-424-C005 | MMP-9 / Lipocalin Complex (human) | 5.micro.g |
ALX-200-425-C005 | MMP-9 / Lipocalin / TIMP-1 Complex (human) | 5.micro.g |
ALX-200-426-C005 | TIMP-1 (human) | 5.micro.g |
ALX-200-427-C005 | TIMP-2 (human) | 5.micro.g |
ALX-200-430-C010 | MMP-9 Proenzyme (human), Monomer | 10.micro.g |
ALX-200-600-5010 | Myeloperoxidase (human leukocytes) | 5x10 U |
ALX-200-600-5025 | Myeloperoxidase (human leukocytes) | 5x25 U |
ALX-200-600-U010 | Myeloperoxidase (human leukocytes) | 10 U |
ALX-200-600-U025 | Myeloperoxidase (human leukocytes) | 25 U |
ALX-200-602-C010 | Granzyme B (human) | 10.micro.g |
ALX-200-603-C050 | Ubiquitin Aldehyde (human) | 50.micro.g |
ALX-200-604-C001 | Perforin (human) | 1.micro.g |
AXL-200-605-C010 | Granzyme A (human) | 10.micro.g |
ALX-201-002-U050 | Furin Convertase (human) (recombinant) | 50 U |
ALX-201-006-M001 | N-Acetyl-eglin C (recombinant) | 1 mg |
ALX-201-006-MC01 | N-Acetyl-eglin C (recombinant) | 0.1 mg |
ALX-201-006-MC05 | N-Acetyl-eglin C (recombinant) | 0.5 mg |
ALX-201-010-C005 | ERK2 (activated) (rat) (recombinant) | 5.micro.g |
ALX-201-012-C250 | PHAS-I (recombinant) | 250.micro.g |
ALX-201-014-C100 | c-Jun N-terminal Kinase Substrate (human) (recombinant) | 100.micro.g |
ALX-201-018-C030 | Annexin V (human) (recombinant) | 30.micro.g |
ALX-201-023-C100 | Cyclophilin A (human) (recombinant) | 100.micro.g |
ALX-201-024-C150 | HSF1 (human) (recombinant) | 150.micro.g |
ALX-201-026-C020 | NF-kappaB (p50) (human) (recombinant) | 20.micro.g |
ALX-201-028-R050 | Nitric Oxide Synthase (Neuronal) (rat) (recombinant) (high purity) | 50.micro.l |
ALX-201-032-C004 | Endothelin-1, Pro- (human) (recombinant) | 4.micro.g |
ALX-201-034-C100 | Leptin (human) (recombinant) | 100.micro.g |
ALX-201-035-C100 | Leptin (mouse) (recombinant) | 100.micro.g |
ALX-201-038-C005 | Caspase-3 (active) (human) (recombinant) | 5.micro.g |
ALX-201-039-C005 | Caspase-6 (active) (human) (recombinant) | 5.micro.g |
ALX-201-040-C005 | Caspase-7 (active) (human) (recombinant) | 5.micro.g |
ALX-201-041-C005 | Caspase-8 (active) (human) (recombinant) | 5.micro.g |
ALX-201-042-C005 | MMP-3 (Catalytic Domain) (human) (recombinant) | 5.micro.g |
ALX-201-044-C250 | SUMO-1 (1-101) (human) (recombinant) | 250.micro.g |
ALX-201-045-C500 | SUMO-1 (1-97) (human) (recombinant) | 500.micro.g |
ALX-201-046-C050 | UbcH9 (recombinant) | 50.micro.g |
ALX-201-047-U025 | Caspase-9 (active) (human) (recombinant) | 25 U |
ALX-201-047-U100 | Caspase-9 (active) (human) (recombinant) | 100 U |
ALX-201-055-C010 | Phosphoinositide 3-kinase p110gamma (human) (recombinant) | 10.micro.g |
ALX-201-056-U025 | Caspase-1 (active) (human) (recombinant) | 25 U |
ALX-201-056-U100 | Caspase-1 (active) (human) (recombinant) | 100 U |
ALX-201-057-U025 | Caspase-2 (active) (human) (recombinant) | 25 U |
ALX-201-057-U100 | Caspase-2 (active) (human) (recombinant) | 100 U |
ALX-201-059-U025 | Caspase-3 (active) (human) (recombinant) | 25 U |
ALX-201-059-U100 | Caspase-3 (active) (human) (recombinant) | 100 U |
ALX-201-060-U025 | Caspase-6 (active) (human) (recombinant) | 25 U |
ALX-201-060-U100 | Caspase-6 (active) (human) (recombinant) | 100 U |
ALX-201-061-U025 | Caspase-7 (active) (human) (recombinant) | 25 U |
ALX-201-061-U100 | Caspase-7 (active) (human) (recombinant) | 100 U |
ALX-201-062-U025 | Caspase-8 (active) (human) (recombinant) | 25 U |
ALX-201-062-U100 | Caspase-8 (active) (human) (recombinant) | 100 U |
ALX-201-063-C020 | PARP-1 (human) (recombinant) (high purity) | 20.micro.g |
ALX-201-064-C020 | PARP-2 (mouse) (recombinant) (high purity) | 20.micro.g |
ALX-201-065-R050 | MGMT (human) (recombinant) | 50.micro.l |
ALX-201-068-R100 | Nitric Oxide Synthase (Neuronal) (human) (recombinant) | 100.micro.l |
ALX-201-069-R100 | Nitric Oxide Synthase (Inducible) (human) (recombinant) | 100.micro.l |
ALX-201-070-R100 | Nitric Oxide Synthase (Endothelial) (human) (recombinant) | 100.micro.l |
ALX-201-071-C005 | cGMP-dependent Protein Kinase Ibeta (human) (recombinant) | 5.micro.g |
ALX-201-072-C005 | cGMP-dependent Protein Kinase II (rat) (recombinant) | 5.micro.g |
ALX-201-073-C020 | KillerTRAIL™, Soluble (human) (recombinant) | 20.micro.g |
ALX-201-074-1 | EGR-1 Protein (human) (recombinant) | 1 Vial |
ALX-201-075-1 | EGR-3 Protein (human) (recombinant) | 1 Vial |
ALX-201-076-1 | EGR-4 Protein (human) (recombinant) | 1 Vial |
ALX-201-077-C010 | DNase I-like Endonuclease 3 (human) | 10.micro.g |
ALX-201-078-C005 | Caspase-3 (rat) (recombinant) | 5.micro.g |
ALX-201-079-C020 | PTEN (human) (recombinant) | 20.micro.g |
ALX-201-081-C020 | Arginase l (human) (recombinant) | 20.micro.g |
ALX-201-082-C005 | Procaspase-3 (human) (recombinant) | 5.micro.g |
ALX-201-084-M001 | NEDD8 Precursor (human) (recombinant) | 1 mg |
ALX-201-085-C500 | NEDD8 (human) (recombinant) | 500.micro.g |
ALX-201-086-C250 | SUMO-2 (1-103) (human) (recombinant) | 250.micro.g |
ALX-201-087-C500 | SUMO-2 (1-92) (human) (recombinant) | 500.micro.g |
ALX-201-088-C250 | SUMO-3 (1-95) (human) (recombinant) | 250.micro.g |
ALX-201-089-C500 | SUMO-3 (1-93) (human) (recombinant) | 500.micro.g |
ALX-201-090-C010 | SUMO-1 Activating Enzyme (human) (recombinant) | 10.micro.g |
ALX-201-091-U025 | Caspase-10/a (active) (human) (recombinant) | 25 U |
ALX-201-091-U100 | Caspase-10/a (active) (human) (recombinant) | 100 U |
ALX-201-092-U025 | Caspase-10/b (active) (human) (recombinant) | 25 U |
ALX-201-092-U100 | Caspase-10/b (active) (human) (recombinant) | 100 U |
ALX-201-093-U025 | Caspase-4 (active) (human) (recombinant) | 25 U |
ALX-201-093-U100 | Caspase-4 (active) (human) (recombinant) | 100 U |
ALX-201-094-U025 | Caspase-5 (active) (human) (recombinant) | 25 U |
ALX-201-094-U100 | Caspase-5 (active) (human) (recombinant) | 100 U |
ALX-201-095-C010 | MMP-2 Proenzyme (human) (recombinant) | 10.micro.g |
ALX-201-096-C020 | MMP-14 (Hemopexin Domain) (human) (recombinant) (His) | 20.micro.g |
ALX-201-097-C010 | MMP-13 (human) (recombinant) (His) | 10.micro.g |
ALX-201-098-C010 | MMP-14 (Catalytic Domain) (human) (recombinant) | 10.micro.g |
ALX-201-099-C010 | MMP-14 Prodomain (Catalytic Domain) (human) (recombinant) (His) | 10.micro.g |
ALX-201-100-C010 | MMP-14 Proenzyme, Soluble (human) (recombinant) (His) | 10.micro.g |
ALX-201-101-C010 | MMP-15 (Catalytic Domain) (human) (recombinant) | 10.micro.g |
ALX-201-103-C010 | MMP-16 (Catalytic Domain) (human) (recombinant) | 10.micro.g |
ALX-201-104-C010 | MMP-17 (Catalytic Domain) (human) (recombinant) (His) | 10.micro.g |
ALX-201-105-C010 | MMP-24 (Catalytic Domain) (human) (recombinant) (His) | 10.micro.g |
ALX-201-106-R050 | Sp1 Protein (human) (recombinant) | 50.micro.l |
ALX-201-107-R050 | Sp3 Protein (human) (recombinant) | 50.micro.l |
ALX-201-110-C020 | Bid (human) (recombinant) | 20.micro.g |
ALX-201-111-C020 | tBid (human) (recombinant) | 20.micro.g |
ALX-201-112-C010 | Granzyme B (human) (recombinant) | 10.micro.g |
ALX-201-115-C010 | SuperKillerTRAIL™, Soluble (human) (recombinant) | 10.micro.g |
ALX-201-116-C100 | Annexin V (human) (recombinant) | 100.micro.g |
ALX-201-117-C010 | Granzyme K (human) (recombinant) | 10.micro.g |
ALX-201-118-C010 | Granzyme A (human) (recombinant) | 10.micro.g |
ALX-201-119-C005 | Phosphoinositide 3-kinase p110alpha/p85 (bovine) (recombinant) | 5 .micro.g |
ALX-201-123-C500 | KillerTRAIL, Soluble (human) (recombinant) (BULK) | 500.micro.g |
ALX-201-124-C010 | PTX3 (human) (recombinant) | 10.micro.g |
ALX-201-125-C050 | Prothymosin alpha (1-99) (human ) (recombinant) | 50.micro.g |
ALX-201-126-C050 | Prothymosin alpha (1-109) (human) (recombinant) | 50.micro.g |
ALX-201-127-U010 | Nitric Oxide Synthase (Endothelial) (bovine) (recombinant) | 10 U |
ALX-201-128-1 | CD26 (human) (recombinant) | 1 Vial |
ALX-201-129-1 | CD26 (rat) (recombinant) | 1 Vial |
ALX-201-130-C020 | SuperKillerTRAIL™, Soluble (mouse) (recombinant) | 20.micro.g |
ALX-201-131-C010 | LBP (human) (recombinant) (His) | 10.micro.g |
ALX-201-132-C010 | LBP (mouse) (recombinant) (His) | 10.micro.g |
ALX-201-133-C010 | CD14 (human) (recombinant) | 10.micro.g |
ALX-201-134-C010 | CD14 (mouse) (recombinant) (His) | 10.micro.g |
ALX-201-135-C005 | Caspase-2 (active) (human) (recombinant) | 5 .micro.g |
ALX-201-136-C005 | Caspase-9 (active) (human) (recombinant) | 5 .micro.g |
ALX-201-137-C005 | Caspase-10 (active) (human) (recombinant) | 5 .micro.g |
ALX-201-138-C025 | HSP90 (yeast) (recombinant) | 25 .micro.g |
ALX-201-139-C025 | HSP26 (yeast) (recombinant) | 25 .micro.g |
ALX-201-140-C025 | HSP12 (yeast) (recombinant) | 25 .micro.g |
ALX-201-141-C025 | GroEL (E. coli) (recombinant) | 25 .micro.g |
ALX-201-142-C025 | GroES (E. coli) (recombinant) | 25 .micro.g |
ALX-201-143-C025 | DnaK (E. coli) (recombinant) | 25 .micro.g |
ALX-201-144-C025 | DnaJ (E. coli) (recombinant) | 25 .micro.g |
ALX-201-145-C025 | GrpE (E. coli) (recombinant) | 25 .micro.g |
ALX-201-146-C025 | HtpG (E. coli) (recombinant) | 25 .micro.g |
ALX-201-147-C025 | HSP90 (human) (recombinant) | 25 .micro.g |
ALX-201-148-C025 | Cdc37 (yeast) (recombinant) | 25 .micro.g |
ALX-201-149-C025 | Sba1 (yeast) (recombinant) | 25 .micro.g |
ALX-201-150-C025 | Peptidyl-prolyl cis-trans Isomerase CPR6 (yeast) (recombinant) | 25 .micro.g |
ALX-201-151-C025 | Sti1 (yeast) (recombinant) | 25 .micro.g |
ALX-201-152-C025 | PDIA2 (human) (recombinant) | 25 .micro.g |
ALX-201-153-C025 | DsbA (E. coli) (recombinant) | 25 .micro.g |
ALX-201-154-C025 | HSP104 (yeast) (recombinant) | 25 .micro.g |
ALX-201-155-R050 | Guanylyl Cyclase, Soluble (human) (recombinant) | 50.micro.l |
ALX-201-156-M001 | Histone H1.0 (human) (recombinant) | 1 mg |
ALX-201-156-M005 | Histone H1.0 (human) (recombinant) | 5 mg |
ALX-201-157-M001 | Histone H1.3 (human) (recombinant) | 1 mg |
ALX-201-157-M005 | Histone H1.3 (human) (recombinant) | 5 mg |
ALX-201-158-M001 | Histone H1.4 (human) (recombinant) | 1 mg |
ALX-201-158-M005 | Histone H1.4 (human) (recombinant) | 5 mg |
ALX-201-159-M001 | Histone H1.5 (human) (recombinant) | 1 mg |
ALX-201-159-M005 | Histone H1.5 (human) (recombinant) | 5 mg |
ALX-201-160-M001 | Histone H1.2 (human) (recombinant) | 1 mg |
ALX-201-160-M005 | Histone H1.2 (human) (recombinant) | 5 mg |
ALX-201-161-C025 | Apaf-1 (rat) (recombinant) (His) | 25.micro.g |
ALX-201-162-C050 | Caspase-3 (active) (mouse) (recombinant) | 50.micro.g |
ALX-201-163-C020 | Caspase-8 (active) (mouse) (recombinant) | 20.micro.g |
ALX-201-164-C050 | Procaspase-9 (human) (recombinant) | 50.micro.g |
ALX-201-165-C050 | Procaspase-9 (mouse) (recombinant) | 50.micro.g |
ALX-201-169-C100 | Resistin (mouse) (recombinant) | 100.micro.g |
ALX-201-170-C020 | PARP-3 (human) (recombinant) (high purity) | 20.micro.g |
ALX-201-171-C050 | NEDP1 (human) (recombinant) | 50.micro.g |
ALX-201-172-C050 | Metallothionein-3 (human) (recombinant) | 50.micro.g |
ALX-201-173-C100 | Midkine (human) (recombinant) | 100.micro.g |
ALX-201-174-C100 | Osteoblast Specific Factor 1 (human) (recombinant) | 100.micro.g |
ALX-201-175-C100 | Osteoblast Specific Factor 2 (human) (recombinant) | 100.micro.g |
ALX-201-176-M001 | Histone gamma-H2AX (human) (rec.) | 1 mg |
ALX-201-176-M005 | Histone gamma-H2AX (human) (rec.) | 5 mg |
ALX-201-177-C010 | Guanylyl Cyclase (alpha1beta1), Soluble (human) (recombinant) | 10.micro.g |
ALX-201-178-C100 | SET7/9 (human) (recombinant) | 100.micro.g |
ALX-201-179-C100 | KIR2DL1 (human) (recombinant) | 100.micro.g |
ALX-201-180-R050 | Guanylyl Cyclase (alpha1beta1), Soluble (human) (recombinant) (enriched) | 50.micro.l |
ALX-201-181-C100 | KIR2DL3 (human) (recombinant) | 100.micro.g |
ALX-201-182-C100 | KIR2DS4 (human) (recombinant) | 100.micro.g |
ALX-201-183-C100 | KIR3DL1 (Cytoplasmic tail) (human) (recombinant) | 100.micro.g |
ALX-201-184-C100 | LAIR-1 (22-125) (human) (recombinant) | 100.micro.g |
ALX-201-185-C100 | NKp46 (22-255) (human) (recombinant) | 100.micro.g |
ALX-201-186-C100 | DnaK (Substrate Binding Domain) (385-546) (recombinant) | 100.micro.g |
ALX-201-187-C100 | DnaK (ATPase Domain) (1-384) (recombinant) | 100.micro.g |
ALX-201-188-C100 | DnaK (Substrate Binding Domain) (385-638) (recombinant) | 100.micro.g |
ALX-201-189-C100 | DnaK (Substrate Covering Lid) (508-638) (recombinant) | 100.micro.g |
ALX-201-190-C100 | HSBP1 (human) (recombinant) | 100.micro.g |
ALX-201-191-C100 | alpha-A-Crystallin (human) (recombinant) | 100.micro.g |
ALX-201-192-C100 | alpha-B-Crystallin (human) (recombinant) | 100.micro.g |
ALX-201-193-U050 | Caspase-10/a (active) (human) (recombinant) (high stability) | 50 U |
ALX-201-194-U050 | Caspase-10/d (active) (human) (recombinant) (high stability) | 50 U |
ALX-201-195-C100 | Resistin (human) (recombinant) | 100.micro.g |
ALX-201-196-C100 | alpha-Synuclein (human) (recombinant) (Mutant, E46K) | 100.micro.g |
ALX-201-197-C100 | gamma-Synuclein (human) (recombinant) | 100.micro.g |
ALX-201-198-C010 | Granulocyte-colony Stimulating Factor (human) (recombinant) | 10.micro.g |
ALX-201-199-C100 | CEBP-alpha (270-358) (human) (recombinant) (His) | 100.micro.g |
ALX-201-200-C100 | CEBP-gamma (39-147) (human) (recombinant) (His) | 100.micro.g |
ALX-201-201-C100 | Growth Hormone (human) (recombinant) | 100.micro.g |
ALX-201-202-C100 | Growth Hormone (20kDa) (human) (recombinant) | 100.micro.g |
ALX-201-203-C100 | Von Hippel-Lindau [VHL] Disease Suppressor Protein (beta-domain) (human) (recombinant) (His) | 100.micro.g |
ALX-201-204-C020 | pro-Bone Morphogenetic Protein 2 (human) (recombinant) | 20.micro.g |
ALX-201-205-C010 | Bone Morphogenetic Protein 2 (human) (recombinant) | 10.micro.g |
ALX-201-206-C020 | Melanoma Inhibitory Activity Protein (human) (recombinant) | 20.micro.g |
ALX-201-207-C020 | pro-beta-Nerve Growth Factor (human) (recombinant) | 20.micro.g |
ALX-201-208-C020 | beta-Nerve Growth Factor (human) (recombinant) | 20.micro.g |
ALX-201-209-C100 | ClpB (E. coli) (recombinant) | 100.micro.g |
ALX-201-210-C025 | Trigger Factor [TF] (E. coli) (recombinant) (His) | 25.micro.g |
ALX-201-211-C025 | HDJ1 (human) (recombinant) | 25.micro.g |
ALX-201-212-C025 | HDJ2 (human) (recombinant) | 25.micro.g |
ALX-201-213-C025 | HSC70 (rat) (recombinant) | 25.micro.g |
ALX-201-214-C025 | HSP70 (human) (recombinant) | 25.micro.g |
ALX-201-215-C025 | CHIP (human) (recombinant) | 25.micro.g |
ALX-201-216-C025 | HIP (human) (recombinant) | 25.micro.g |
ALX-201-217-C100 | DnaK (1-638) (E. coli) (recombinant) | 100.micro.g |
ALX-201-218-C025 | Hop (human) (recombinant) | 25.micro.g |
ALX-201-219-C025 | BiP (human) (recombinant) | 25.micro.g |
ALX-201-220-C025 | Calnexin (human) (recombinant) | 25.micro.g |
ALX-201-221-C100 | Pin1 (human) (recombinant) | 100.micro.g |
ALX-201-222-C200 | p43 [pro-EMAPII] (human) (recombinant) | 200.micro.g |
ALX-201-223-1 | EGR-2 Protein (human) (recombinant) | 1 Vial |
ALX-201-224-C025 | cAMP-dependent Protein Kinase (Catalytic Subunit Calpha) (mouse) (recombinant) | 25.micro.g |
ALX-201-224-C050 | cAMP-dependent Protein Kinase (Catalytic Subunit Calpha) (mouse) (recombinant) | 50.micro.g |
ALX-201-224-C100 | cAMP-dependent Protein Kinase (Catalytic Subunit Calpha) (mouse) (recombinant) | 100.micro.g |
ALX-201-225-C025 | cAMP-dependent Protein Kinase (Regulatory Subunit RIalpha) (bovine) (recombinant) | 25.micro.g |
ALX-201-225-C050 | cAMP-dependent Protein Kinase (Regulatory Subunit RIalpha) (bovine) (recombinant) | 50.micro.g |
ALX-201-225-C100 | cAMP-dependent Protein Kinase (Regulatory Subunit RIalpha) (bovine) (recombinant) | 100.micro.g |
ALX-201-226-C025 | cAMP-dependent Protein Kinase (Regulatory Subunit RIIalpha) (human) (recombinant) | 25.micro.g |
ALX-201-226-C050 | cAMP-dependent Protein Kinase (Regulatory Subunit RIIalpha) (human) (recombinant) | 50.micro.g |
ALX-201-226-C100 | cAMP-dependent Protein Kinase (Regulatory Subunit RIIalpha) (human) (recombinant) | 100.micro.g |
ALX-201-227-C025 | cAMP-dependent Protein Kinase (Regulatory Subunit RIIbeta) (rat) (recombinant) | 25.micro.g |
ALX-201-227-C050 | cAMP-dependent Protein Kinase (Regulatory Subunit RIIbeta) (rat) (recombinant) | 50.micro.g |
ALX-201-227-C100 | cAMP-dependent Protein Kinase (Regulatory Subunit RIIbeta) (rat) (recombinant) | 100.micro.g |
ALX-201-228-C020 | cAMP-dependent Protein Kinase (Holoenzyme Type Ialpha, Calpha2 (mouse)/RIalpha2 (bovine)) (recombinant) | 20.micro.g |
ALX-201-228-C050 | cAMP-dependent Protein Kinase (Holoenzyme Type Ialpha, Calpha2 (mouse)/RIalpha2 (bovine)) (recombinant) | 50.micro.g |
ALX-201-228-C100 | cAMP-dependent Protein Kinase (Holoenzyme Type Ialpha, Calpha2 (mouse)/RIalpha2 (bovine)) (recombinant) | 100.mciro.g |
ALX-201-229-C020 | cAMP-dependent Protein Kinase (Holoenzyme Type IIalpha, Calpha2 (mouse)/RIIalpha2 (human)) (recombinant) | 20.micro.g |
ALX-201-229-C050 | cAMP-dependent Protein Kinase (Holoenzyme Type IIalpha, Calpha2 (mouse)/RIIalpha2 (human)) (recombinant) | 50.micro.g |
ALX-201-229-C100 | cAMP-dependent Protein Kinase (Holoenzyme Type IIalpha, Calpha2 (mouse)/RIIalpha2 (human)) (recombinant) | 100.micro.g |
ALX-201-230-C020 | Endonuclease G (rat) (rec.) | 20.micro.g |
ALX-201-231-C100 | Leptin (rat) (rec.) | 100.micro.g |
ALX-201-232-C020 | PARP-1 (Catalytic Domain) (human) (recombinant) (His) | 20.micro.g |
ALX-201-233-C005 | Rad9/Rad1/Hus1 [9-1-1 Complex] (human) (rec.) | 5.micro.g |
ALX-201-234-C025 | Proliferating Cell Nuclear Antigen [PCNA] (human) (rec.) | 25.micro.g |
ALX-201-235-C050 | NAD Kinase (full length) (human) (rec.) | 50.micro.g |
ALX-201-236-C050 | NAD Kinase (truncated NT) (human) (rec.) | 50.micro.g |
ALX-201-300-C050 | Adiponectin, Soluble (human) (recombinant) (His) | 50.micro.g |
ALX-201-301-C050 | Adiponectin, Soluble (mouse) (recombinant) | 50.micro.g |
ALX-201-302-C050 | Adiponectin, Soluble (mouse) (recombinant) (His) | 50.micro.g |
ALX-201-303-C050 | Adiponectin [ACRP30] (rat) (recombinant) (FLAG) | 50.micro.g |
ALX-201-304-C050 | Adiponectin, Soluble (human) (globular domain) (His) | 50.micro.g |
ALX-201-305-C050 | Adiponectin, Soluble (human) (globular domain) | 50.micro.g |
ALX-201-306-C050 | Adiponectin, Soluble (mouse) (globular domain) (His) | 50.micro.g |
ALX-201-307-C050 | GITRL, Soluble (mouse) (recombinant) | 50.micro.g |
ALX-201-308-C050 | GITRL, Soluble (mouse) (recombinant) (His) | 50.micro.g |
ALX-201-309-C050 | Resistin, Soluble (human) (recombinant) | 50.micro.g |
ALX-201-310-C050 | Resistin, Soluble (mouse) (recombinant) | 50.micro.g |
ALX-201-311-C050 | Resistin, Soluble (rat) (recombinant) | 50.micro.g |
ALX-201-312-C050 | Resistin (rat) (recombinant) (His) | 50.micro.g |
ALX-201-313-C010 | Angiopoietin-1 (human) (recombinant) (FLAG) | 10.micro.g |
ALX-201-313-C050 | Angiopoietin-1 (human) (recombinant) (FLAG) | 50.micro.g |
ALX-201-314-C010 | COMP-Angiopoietin-1 (human) (recombinant) (FLAG) | 10.micro.g |
ALX-201-314-C050 | COMP-Angiopoietin-1 (human) (recombinant) (FLAG) | 50.micro.g |
ALX-201-314-C500 | COMP-Angiopoietin-1 (human) (recombinant) (FLAG) | 500.micro.g |
ALX-201-315-C010 | Angiopoietin-2 (human) (recombinant) (FLAG) | 10.micro.g |
ALX-201-315-C050 | Angiopoietin-2 (human) (recombinant) (FLAG) | 50.micro.g |
ALX-201-318-C050 | Visfatin (mouse) (recombinant) (His) | 50.micro.g |
ALX-201-319-C050 | Visfatin (human) (recombinant) (His) | 50.micro.g |
ALX-201-320-C050 | GITRL (human) (recombinant) (FLAG) | 50.micro.g |
ALX-201-321-C050 | CD137L [4-1BBL] (mouse) (recombinant) (FLAG) | 50.micro.g |
ALX-201-323-C050 | Adiponectin [ACRP30] (rat) (recombinant) (His) | 50.micro.g |
ALX-201-324-C050 | Adiponectin [ACRP30] (Globular Domain) (rat) (recombinant) (His) | 50.micro.g |
ALX-201-325-C050 | RELM-beta (mouse) (recombinant) (FLAG) | 50.micro.g |
ALX-201-327-C050 | GITRL (human) (recombinant) (His) | 50.micro.g |
ALX-201-329-C050 | CD137 [4-1BB] (mouse):Fc (human) (recombinant) | 50.micro.g |
ALX-201-330-C050 | ACE2 (human):Fc (human) (recombinant) | 50.micro.g |
ALX-201-332-C050 | Visfatin (rat) (recombinant) (His) | 50.micro.g |
ALX-201-333-C050 | IDO (human) (recombinant) (His) | 50.micro.g |
ALX-201-334-C050 | SOCS-3 (human) (recombinant) (His) | 50.micro.g |
ALX-201-335-C050 | IDO (mouse) (recombinant) (His) | 50.micro.g |
ALX-201-336-C010 | Visfatin (human) (recombinant) (FLAG) | 10.micro.g |
ALX-201-336-C050 | Visfatin (human) (recombinant) (FLAG) | 50.micro.g |
ALX-201-337-C010 | AGF (human) (recombinant) (FLAG) | 10.micro.g |
ALX-201-337-C050 | AGF (human) (recombinant) (FLAG) | 50.micro.g |
ALX-201-338-C010 | Angiopoietin-like Protein 4 (human) (recombinant) (FLAG) | 10.micro.g |
ALX-201-338-C050 | Angiopoietin-like Protein 4 (human) (recombinant) (FLAG) | 50.micro.g |
ALX-201-339-C050 | Retinol Binding Protein 4 [RBP4] (human) (recombinant) (His) | 50.micro.g |
ALX-201-339-C100 | Retinol Binding Protein 4 [RBP4] (human) (recombinant) (His) | 100.micro.g |
ALX-201-339-C500 | Retinol Binding Protein 4 [RBP4] (human) (recombinant) (His) | 500.micro.g |
ALX-201-340-C050 | Fatty Acid Binding Protein 4 [FABP4] (human) (recombinant) (His) | 50.micro.g |
ALX-201-341-C050 | Fatty Acid Binding Protein 3 [FABP3] (human) (recombinant) (His) | 50.micro.g |
ALX-201-342-C010 | Glutathione Peroxidase 3 [GPX3] (human) (recombinant) (His) | 10.micro.g |
ALX-201-342-C050 | Glutathione Peroxidase 3 [GPX3] (human) (recombinant) (His) | 50.micro.g |
ALX-201-343-C010 | IL-23 (human) (rec.) (FLAG) | 10.micro.g |
ALX-201-343-C050 | IL-23 (human) (rec.) (FLAG) | 50.micro.g |
ALX-201-344-C050 | Fatty Acid Binding Protein 1 [FABP1] (human) (rec.) (His) | 50.micro.g |